Quidel Molecular Direct C. difficile Assay
|
The Quidel® Molecular Direct C. difficile Assay is a qualitative, multiplexed in vitro diagnostic test for the direct detection of toxin A gene (tcdA) or toxin B gene (tcdB) sequences of toxigenic strains of Clostridium difficile from unformed (liquid or soft) stool specimens collected from patients suspected of having Clostridium difficile-Associated Disease (CDAD).
Benefits of Quidel® Molecular Direct C. difficile Assay Kits
| Benefits |
|---|
| CE-IVD labelled |
| Cleared for use in the US with Life Technologies QuantStudio™ Dx and Applied Biosystems® 7500 Fast Dx |
| The Quidel® Molecular Direct C. difficile Assay is a qualitative, multiplexed in vitro diagnostic test for the direct detection of toxin A gene (tcdA) or toxin B gene (tcdB) sequences of toxigenic strains of Clostridium difficile from unformed (liquid or soft) stool specimens collected from patients suspected of having Clostridium difficile-Associated Disease (CDAD). |
| Helps achieve 99% sensitivity and 99% specificity |
| No sample prep required (just two dilutions) |
Product Information
| US | Europe |
|---|---|
|
Ordering Information
Product |
Quantity |
Cat. No. |
Quidel® Molecular Direct C. difficile Assay |
96 reactions |
4476855 |
Quidel® Molecular Direct C. difficile External Controls |
10 reactions |
4477229 |
